Jehovah’s Witnesses announced a revised policy that permits the use of certain blood-derived products while continuing to reject whole-blood transfusions.
The Story
Jehovah’s Witnesses have announced a change to their approach to medical blood use, allowing members to receive treatments made from donated blood while still prohibiting transfusions of whole blood. The announcement was made Friday and is described as the second revision to the organization’s blood policy this year, a teaching that has long been among the group’s most distinctive and controversial positions.
Under the updated policy, individuals may receive medical products derived from blood donated by other people. The organization also stated that members may receive medical treatments that involve the four main components of whole blood, including plasma, platelets and red and white blood cells. The policy does not remove the organization’s broader constraint on whole-blood transfusions.
A core element of the announcement is the emphasis on individual choice. In remarks attributed to Geoffrey W. Jackson, a member of the Governing Body based in New York State, the policy says each Christian must make a personal decision about whether to use those blood components in medical and surgical care.
Alongside what members may receive, the policy also addresses donation. Jehovah’s Witnesses said the new announcement allows members to decide, as a matter of individual conscience, whether to donate blood that could be used for blood products for the medical treatment of others. The organization continues to oppose members receiving transfusions of whole blood or donating blood for that purpose.
The update comes after another change earlier in 2026. In March, the Governing Body announced a revision allowing members to have their blood stored for their own future medical treatment, but not for use by others. Taken together, the two revisions show a shift in how the organization frames the boundaries of acceptable blood-related medical practice.
Critics have raised objections to Jehovah’s Witnesses’ overall stance on transfusions, arguing it has deprived adherents of a treatment they say can be lifesaving in emergencies and major injuries. In particular, critics including former members have faulted the policy for discouraging the use of whole-blood transfusions in situations involving blood loss in surgeries, accidents or violence.
The organization’s rationale remains rooted in its interpretation of Bible passages that call on believers to “abstain” from blood. Jehovah’s Witnesses interpret that instruction as extending beyond dietary practice to include medical transfusions, a view that sets them apart from many other Christian groups and from Jewish and other Christian traditions that have treated the biblical instruction more narrowly.
Religious officials framed the decision-making process as one that requires spiritual reflection and study. In an interview reported alongside the announcement, Paul Gillies, identified as an international spokesperson for Jehovah’s Witnesses, said members should not make blood-related decisions lightly, describing the need to pray, study and consider what the Bible says, since blood in biblical teaching is associated with life.
The organization’s announcement also helps clarify how blood components are used in healthcare. Blood components are often administered for different medical purposes rather than as a single whole product; plasma, for example, is described as being used for trauma and certain diseases, while red cells are used for conditions such as anemia and white cells for certain infections. Platelets are also used for some cancer and other treatments, according to the information provided.
Jehovah’s Witnesses trace their origins to 19th-century America and say they share many Christian beliefs with other churches, while differing on key theological issues such as the nature of Jesus and biblical prophecy. The organization’s blood transfusion position has been a defining divergence from most other Christian traditions, and it continues to be among the issues that draw outside attention when the group revises its policies.
In terms of scale, Jehovah’s Witnesses reported membership numbers of 1.3 million in the United States in 2025, and a worldwide membership of 9.2 million across more than 200 countries and territories. For Canadian readers, the update underscores how religiously informed medical decisions can change over time and why hospitals and patients may need to understand the practical distinctions between whole-blood transfusions and component-based blood treatments when planning care.
For people who are Jehovah’s Witnesses, the policy shift may affect how consent and medical planning discussions occur with healthcare providers, particularly in settings involving surgeries or conditions where blood product use is considered. More broadly, the announcement reflects the continuing tension between religious directives and modern medical options, especially when the differences between whole blood and its components can determine what treatments may be acceptable to individual members.
← More stories